Skip to main content
KTTA
NASDAQ Life Sciences

Pasithea Therapeutics Narrows Q1 Net Loss to $2.87M, EPS Improves to $(0.12)

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.8
Mkt Cap
$19.456M
52W Low
$0.281
52W High
$2.06
52W Position info
185% above low
Off High info
61% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

KTTA has more than doubled off its 52-week low of $0.281.

Summary

Pasithea Therapeutics Corp. reported its first-quarter 2026 financial results, showing a net loss of $(2.87) million, a significant improvement from the $(3.56) million loss in Q1 2025. Diluted loss per share also improved to $(0.12) from $(1.61) year-over-year. This positive financial trend, coupled with ongoing Phase 1 dose-escalation trials for PAS-004 and IND clearance for registrational programs, provides a crucial update on the company's progress. The company also highlighted sufficient cash for at least 12 months, with future funding potentially relying on equity, debt, or partnerships. Traders will monitor continued clinical advancements and future financing strategies.

At the time of this announcement, KTTA was trading at $0.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $19.5M. The 52-week trading range was $0.28 to $2.06. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KTTA - Latest Insights

KTTA
Nov 03, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3591
Real-time Price: $0.580 info
Change: +$0.2209 (+62%) info
Market Cap: $19.34M info
KTTA
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.580 info
Change: +$0.030 (+5%) info
Market Cap: $19.34M info
KTTA
Sep 09, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5697
Real-time Price: $0.580 info
Change: +$0.0103 (+2%) info
Market Cap: $19.34M info
KTTA
Aug 21, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.490
Real-time Price: $0.580 info
Change: +$0.090 (+18%) info
Market Cap: $19.34M info
KTTA
Jul 29, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4231
Real-time Price: $0.580 info
Change: +$0.1569 (+37%) info
Market Cap: $19.34M info